CardiNor has secured NOK12 million (US$1.46M) to commercialize first secretoneurin ELISA test
The growing heart failure pandemic increases need for new innovative assays
The growing heart failure pandemic increases need for new innovative assays
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications
Pushing the spatial genomics frontier one biomolecule at a time from RNA to DNA
In this guest editorial, Fritz Gyger AG shares how the revolutionary Droplet Microarray provides a solution to the limitations currently faced when using traditional microplates
The new emerging variant panel add-on for use with existing CleanPlex SARS-CoV-2 products allows researchers to easily maintain confident variant identification as the virus evolves
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
Explore topics from AAV gene therapy and food fraud advances to LC-MS and Raman spectroscopy for drug discovery
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
The assays will help public health researchers track SARS-CoV-2 variants more rapidly and cost-effectively
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more